YI CHENG ZHI HUI LTD.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
AIxMed’s flagship solution, AIxURO™, is an AI-powered platform for urine cytology. It applies The Paris System for Reporting Urinary Cytology (TPS) to detect and classify atypical and suspicious cells, helping pathologists by offering quantitative risk an
Founded Year
2018
Unified Business No.
50894308
Status
Active
Number of Employees
0
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AIxMed Inc., founded in 2018 and headquartered in Silicon Valley with a presence in Taiwan, is a health‑tech company that combines artificial intelligence with computational cytology. Their mission is to transform cancer diagnosis by applying machine learning and computer vision to cellular imaging, thereby improving diagnostic workflows and patient outcomes.
